Consistently, at the molecular level, KDM4A KD led to transcriptional changes distinct from KDM4C KD via GSEA comparison (Fig. S6C), further supporting a unique role for KDM4A compared to KDM4C in human AML. This evidence concerns the gene KDM4A and acute myeloid leukemia.